Testosterone Cypionate is owned by Slayback Pharma Llc.
Testosterone Cypionate contains Testosterone Cypionate.
Testosterone Cypionate has a total of 1 drug patent out of which 0 drug patents have expired.
Testosterone Cypionate was authorised for market use on 02 June, 2022.
Testosterone Cypionate is available in solution;intramuscular dosage forms.
The generics of Testosterone Cypionate are possible to be released after 25 March, 2039.
|Patent Number||Company||Patent Title||Patent Expiry||Activity Alert|
|These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).|
|US11311554||SLAYBACK PHARMA LLC||Pharmaceutical compositions of testosterone|| |
(16 years from now)
Drugs and Companies using TESTOSTERONE CYPIONATE ingredient
Market Authorisation Date: 02 June, 2022
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic